Ophthalmology · North Miami Beach, FL
NPI
1932196292
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
182 NE 168th St
North Miami Beach, FL, 33162
Phone (305) 651-4300
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
276 services
Medicare patients, 2024
126
Average age 72
Drug cost, 2024
$1.3M
9,609 prescriptions
Company payments, 2025
$466
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John A Puglisi was code 92012 (ophthalmological e&m), 103 times for 65 patients. In total John A Puglisi billed 276 services in 12 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 103 | 65 | $56.58 | $5,827 |
| 92014 Ophthalmological E&M | Office | 65 | 63 | $83.72 | $5,442 |
| 92083 Vision, Hearing, and Speech Services | Office | 37 | 37 | $43.66 | $1,615 |
| 92004 Ophthalmological E&M | Office | 28 | 28 | $93.16 | $2,609 |
| 92133 Computerized Ophthalmic Imaging | Office | 24 | 24 | $23.81 | $572 |
By year: 2022 $22K for 367 services; 2023 $24K for 350 services; 2024 $17K for 276 services.
Medicare prescription drug claims, 2024
In 2024, the drug John A Puglisi prescribed most often to Medicare patients was Latanoprost, with 3,442 prescriptions and refills. In total John A Puglisi wrote 9,609 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 3,442 | 6,956 | 1,031 | $37K |
| Timolol Maleate Generic | 892 | 1,832 | 297 | $12K |
| Combigan Brimonidine Tartrate/Timolol | 784 | 1,353 | 216 | $301K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 765 | 1,590 | 255 | $13K |
| Lumigan Bimatoprost | 640 | 1,074 | 189 | $276K |
| Brimonidine Tartrate Generic | 597 | 1,161 | 193 | $18K |
| Dorzolamide Hcl Generic | 531 | 1,132 | 181 | $10K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 391 | 624 | 113 | $65K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 325 | 541 | 87 | $200K |
| Alphagan P Brimonidine Tartrate | 264 | 483 | 79 | $103K |
| Prednisolone Acetate Generic | 171 | 241 | 109 | $7,578 |
| Travoprost Generic | 155 | 281 | 41 | $25K |
| Vyzulta Latanoprostene Bunod | 101 | 193 | 41 | $47K |
| Restasis Cyclosporine | 84 | 132 | 30 | $76K |
| Restasis Multidose Cyclosporine | 77 | 93 | 19 | $57K |
Brand drugs: 4,291 claims; generic drugs: 5,318 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John A Puglisi $466 ($466 in general payments such as food, travel and fees) from 4 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $233.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.